This article is more than 5 years old. Information may no longer be current.

NYU Langone names gynecologic oncology division director

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Douglas A. Levine, MD, FACOG, FACS, has been named director of the division of gynecologic oncology at NYU Langone Medical Center’s Laura and Isaac Perlmutter Cancer Center.

Levine, a surgeon and scientist whose research has helped advance early detection and treatment of ovarian cancer, will assume his new role on May 15.

Levine previously served as attending physician and head of the gynecology research laboratory at Memorial Sloan Kettering Cancer Center.

While there, he served as a translational scientist on many clinical trials designed to determine what genomic alterations are associated with response to targeted therapies.

“Dr. Levine’s work sets the stage for greater understanding of why ovarian cancers start and how we can treat them better once they develop,” Benjamin G. Neel, MD, PhD, director of Perlmutter Cancer Center, said in a press release. “These contributions to the field have been practice-changing, providing new insights and innovations in how we think about and approach ovarian cancer.”